Ameritas Investment Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-596
Closed -$146K 3062
2022
Q3
$146K Hold
596
0.01% 1243
2022
Q2
$147K Hold
596
0.01% 1251
2022
Q1
$197K Hold
596
0.01% 1195
2021
Q4
$214K Sell
596
-61
-9% -$20.6K 0.01% 1195
2021
Q3
$214K Hold
657
0.01% 1153
2021
Q2
$205K Hold
657
0.01% 1232
2021
Q1
$209K Hold
657
0.01% 1180
2020
Q4
$213K Sell
657
-65
-9% -$18K 0.01% 1107
2020
Q3
$200K Hold
722
0.01% 1031
2020
Q2
$174K Sell
722
-78
-10% -$15.7K 0.01% 1079
2020
Q1
$116K Hold
800
0.01% 1188
2019
Q4
$136K Hold
800
0.01% 1322
2019
Q3
$142K Hold
800
0.01% 1254
2019
Q2
$208K Hold
800
0.01% 1039
2019
Q1
$228K Hold
800
0.01% 980
2018
Q4
$260K Hold
800
0.01% 860
2018
Q3
$360K Hold
800
0.02% 821
2018
Q2
$327K Sell
800
-11,754
-94% -$4.26M 0.02% 839
2018
Q1
$3.65M Hold
12,554
0.18% 101
2017
Q4
$2.35M Buy
12,554
+359
+3% +$67K 0.11% 207
2017
Q3
$1.84M Hold
12,195
0.09% 271
2017
Q2
$1.75M Buy
12,195
+259
+2% +$34.8K 0.08% 276
2017
Q1
$1.49M Sell
11,936
-170
-1% -$19.7K 0.07% 334
2016
Q4
$1.36M Buy
12,106
+110
+0.9% +$12.7K 0.07% 373
2016
Q3
$1.54M Buy
11,996
+5,779
+93% +$692K 0.08% 298
2016
Q2
$679K Sell
6,217
-2,954
-32% -$294K 0.04% 458
2016
Q1
$870K Buy
9,171
+5,950
+185% +$502K 0.06% 352
2015
Q4
$291K Hold
3,221
0.02% 810
2015
Q3
$299K Hold
3,221
0.02% 766
2015
Q2
$212K Sell
3,221
-298
-8% -$19.8K 0.01% 948
2015
Q1
$252K Buy
+3,519
New +$191K 0.02% 915

Other funds holding ABMD

Ameritas Investment Partners's ABMD Position: Q4 2022 in Review

Ameritas Investment Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 596 shares — an estimated $146K sold.

Ameritas Investment Partners first reported a position in ABMD in Q1 2015 and held it in 31 quarters. The position peaked at $3.65M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Ameritas Investment Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 596 Abiomed Inc shares in Q4 2022, an estimated $146K.
  • Ameritas Investment Partners first reported a position in Abiomed Inc in Q1 2015 and held it in 31 quarters.
  • Ameritas Investment Partners's Abiomed Inc position peaked at $3.65M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.